Clinical Trial Update: InfasurfAero™ Versus Sham Treatment in Preterm Newborns With RDS [Phase 3]

View source ↗

Summary

This entry describes a Phase 3 clinical trial evaluating InfasurfAero™ versus sham treatment in preterm newborns with neonatal respiratory distress syndrome, wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• InfasurfAero™

Snippet

Sponsor: ONY | Conditions: Respiratory Distress Syndrome (Neonatal), Intubation Complication | Phase 3 | Status: RECRUITING